首页> 外文期刊>Medicinal chemistry >Structure activity relationship of arylidene pyrrolo and pyrido [2,1-b] Quinazolones as cytotoxic agents: synthesis, SAR studies, biological evaluation and docking studies.
【24h】

Structure activity relationship of arylidene pyrrolo and pyrido [2,1-b] Quinazolones as cytotoxic agents: synthesis, SAR studies, biological evaluation and docking studies.

机译:芳基吡咯烷酮和吡啶基[2,1-b]喹唑酮类作为细胞毒剂的结构活性关系:合成,SAR研究,生物学评估和对接研究。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Tubulin is the one of the most useful and strategic molecular targets for anticancer drugs. Agents that bind in Colchicine-binding site of tubulin include Phenstatin, Combretastatin A-4, Colchicine, Steganacin, Podophyllotoxin and certain other synthetic analogues of these compounds. Arylidene pyrollo and pyrido [2,1- b] quinazolones (isoindigatone and its synthetic analogues) have been earlier reported to be tubulin inhibitors evidenced by tubulin polymerization assay. The present study is an extension of the library of the isoindigatone and its synthetic analogues to generate the structure activity relationship. The study explores the role of the arylidene ring and also provides some intresting observations such as the placement of bicyclic ring such as naphylidene for potential activity. Some of the important interactions of KNH- 3 and KNH-11 with the amino acid residues of active site of Tubulin have also been observed by molecular modeling.
机译:微管蛋白是抗癌药物最有用和最具战略意义的分子靶标之一。在微管蛋白的秋水仙碱结合位点结合的药剂包括苯乙他汀,Combretastatin A-4,秋水仙碱,Steganacin,鬼臼毒素和这些化合物的某些其他合成类似物。早先已有报道称亚苄基吡咯烷和吡啶基[2,1-b]喹唑酮类(异茚二酮及其合成类似物)是微管蛋白聚合试验所证实的微管蛋白抑制剂。本研究是异英酮及其合成类似物文库的扩展,以产生结构活性关系。该研究探索了亚芳基环的作用,并提供了一些引人入胜的观察结果,例如将双环(如萘啶酮)放置在潜在活性上。还已经通过分子建模观察到了KNH-3和KNH-11与微管蛋白活性位点的氨基酸残基的一些重要相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号